GlassScriptPhysician profile
Jen F Lee
NPI 1942244827
$2,964.73
in general payments reported to CMS, 2019-2025
30 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $178 · 2021: $481 · 2022: $835 · 2023: $515 · 2024: $309 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $399.95 | 2020-2024 | Tapestry, Stratum Foot Plating System |
| Fidia Pharma USA INC. | $362.12 | 2019-2025 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $250.32 | 2022-2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $227.63 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $217.01 | 2019-2024 | Orthovisc |
| Medtronic, INC. | $162.23 | 2022-2025 | Anatomic Peek Ptc Cervical Fusion System |
| Nuvasive, INC. | $150.10 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $131.54 | 2019-2023 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $131.03 | 2019-2022 | |
| Incyte Corporation | $119.55 | 2021 | |
| Horizon Therapeutics Plc | $114.33 | 2019-2022 | |
| Bioventus LLC | $98.60 | 2020-2022 | |
| Pacira Therapeutics, INC. | $87.80 | 2019-2021 | |
| Stryker Corporation | $67.77 | 2023-2025 | Alphavent, Inspace, Simpliciti |
| Heron Therapeutics, INC. | $65.35 | 2021-2024 | Zynrelef |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $65.16 | 2022 | |
| Globus Medical, INC. | $43.81 | 2023 | Proximal Humerus Strut |
| Trevena, INC. | $39.83 | 2021-2022 | |
| Integra Lifesciences Corporation | $30.00 | 2019 | |
| Zyla Life Sciences, INC. | $28.06 | 2019 | |
| Misonix INC | $25.53 | 2021 | |
| Avanos Medical | $19.41 | 2022 | |
| Axogen | $17.79 | 2019 | |
| Heraeus Medical, LLC. | $17.56 | 2024 | |
| Endo USA, INC. | $17.45 | 2024 | Xiaflex |
| Pfizer INC. | $16.33 | 2024 | |
| Orthofix Medical, INC. | $15.89 | 2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $15.33 | 2025 | Exparel |
| Vericel Corporation | $13.73 | 2023 | Maci |
| Sonex Health, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jen Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.